Dear Editor, Although the interaction between TB and COVID-19 is unclear, recent evidence
suggests that COVID-19 could worsen the outcome of active pulmonary TB or aggravate …

COVID-19, the novel coronavirus pandemic, has already spread around the globe affecting
more than 18 million people. As previously observed with other coronaviruses, SARS-CoV-2 …

Background/objectives Patients infected with SARS-COV-2 were observed to have a
significant occurrence of indeterminate results in interferon-gamma (IFN-ɣ) release assays …

Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs)
for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown …

Dear Editor, At the time of writing, COVID-19 has killed more than 2.5 million people
globally. 1 A limited number of studies have indicated that TB may be a risk factor for poor …

Dear Editor, We report here on the detrimental impact that the COVID-19 pandemic has had
on testing for TB infection, with a sharp decrease in tests performed at the primary UK …

Dear Editor, The global COVID-19 pandemic has already resulted in more than 5 million
cases and. 300 000 deaths. 1 Five of the 55 COVID-19 patients (diagnosed according to the …

Dear Editor, We read with great interest the article by Dara et al, 1 on how to apply lessons
learned from TB to the COVID-19 response. For too long, TB has been overshadowed by …

Background The clinical and epidemiological implications of abnormal immune responses
in COVID-19 for latent tuberculosis infection (LTBI) screening are unclear. Methods We …

The COVID-19 pandemic has resulted in huge changes in healthcare services, especially in
resource allocation, manpower and infrastructure. 1, 2 Consequently, other healthcare …